(Q28608404)

2

0 references

Ryo Sato

3

0 references

Kanta Oikawa

4

0 references

Hiroyuki Yamada

5

0 references

Seizo Oriso

6

0 references

Sadahide Ono

7

0 references

Akiko Yashima-Abo

8

0 references

Koji Kotani

9

0 references

Kazuyuki Suzuki

10

0 references

Tomoyuki Masuda

World Journal of Gastroenterology

11

0 references

language of work or name

English

0 references

publication date

14 September 2005

0 references

published in

0 references

volume

11

0 references

issue

34

0 references

page(s)

5394-7

0 references

cites work

The potential role of genes in nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

The ins and outs of mitochondrial dysfunction in NASH.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Low dose amiodarone causing pseudo-alcoholic cirrhosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Drugs and steatohepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Long-term efficacy and toxicity of high- and low-dose amiodarone regimens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Hepatotoxicity associated with amiodarone therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Histopathologic analysis of suspected amiodarone hepatotoxicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Amiodarone-associated cirrhosis with hepatic and lymph node granulomas

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

3 June 2018

Amiodarone and the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Amiodarone hepatotoxicity

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4622818

Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.

3 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I34.5394

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I34.5394

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I34.5394

Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I34.5394

Amiodarone hepatotoxicity: progression from steatosis to cirrhosis

21 January 2018

1 reference

12 December 2020

Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients

1 reference

12 December 2020

Amiodarone hepatotoxicity simulating alcoholic liver disease

1 reference

12 December 2020

Chronic liver disease after low daily doses of amiodarone. Report of three cases

1 reference

12 December 2020

Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice

1 reference

12 December 2020

Adverse effects of low dose amiodarone: a meta-analysis

1 reference

12 December 2020

1 reference

12 December 2020

Fatal amiodarone hepatoxicity

1 reference

12 December 2020

Amiodarone-induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease

1 reference

12 December 2020

Safety and efficacy of amiodarone. The low-dose perspective

1 reference

12 December 2020